Axillary sentinel lymph node biopsy: An overview

International Journal of Surgery

Volumn 6, Issue SUPPL. 1, 2008, Pages

  Rovera, Francesca ^a   Frattini, Francesco ^a   Marelli, Marina ^a   Corben, Adriana Dionigi ^b   Dionigi, Gianlorenzo ^a   Boni, Luigi ^a   Dionigi, Renzo ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Axillary dissection; Blue dye tracer; Cytokeratins; Early breast cancer; Radiocolloid tracer; Sentinel lymph nodes biopsy; SLNB

Indexed keywords

ALBUMIN TC 99M; ANTINEOPLASTIC AGENT; CYTOKERATIN; EOSIN; HEMATOXYLIN; ISOSULFAN BLUE; RADIOACTIVE COLLOID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLLOID; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BREAST CANCER; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MASTECTOMY; METASTASIS POTENTIAL; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 63449118585     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2008.12.008     Document Type: Article

References (22)

1. Schwartz G.F., Giuliano A.E., Veronesi U., and The Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. April 19-22, 2001, Philadelphia. Cancer 94 (2002) 2542-2551
2. Lyman G.H., Giuliano A.E., Somerfield M.R., Bensen A.I., Bodurka D.C., Burstein H.J., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
3. Carter C., Allen C., and Henson D.E. Relation of tumor size, lymph node status and survival in 24740 breast cancer cases. Cancer 63 (1989) 181-187
4. Chung M.H., Ye W., and Giuliano A.E. Role for sentinel lymph node dissection in the management of large (>5 cm) invasive breast cancer. Ann Surg Oncol 8 (2001) 688-692
5. Gimbergues P., Abrial C., Durando X., Le Bouedec G., Cachin F., Penault-Llorca F., et al. Sentinel node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 15 (2008) 1316-1321
6. Reitsamer R., Peitinger F., Rettenbacher L., and Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 84 (2003) 63-67
7. Mamounas E.P., Brown A., Smith R., Julian T., Miller B., Bear H.D., et al. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: updated results from NSABP B-27. J Clin Oncol 23 12 (2005 Apr) 2694-2702
8. Kumar R., Jana S., Heiba S.I., Dakhel M., Axelrod D., Siegel B., et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or non palpable breast cancer. J Nucl Med 44 (2003) 7-10
9. Shrenk P., and Wayand W. Sentinel node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 357 (2001) 122
10. Intra M., Veronesi P., Mazzarol G., Galimberti V., Luini A., Sacchini V., et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138 (2003) 309-313
11. Haigh P.I., Hansen N.M., Qi K., and Giuliano A.E. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7 (2000) 21-27
12. Port E.R., Fey J., Gemignani M.L., Heerdt A.S., Montgomery L.L., Petrek J.A., et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 195 (2002) 167-172
13. Veronesi U., Galimberti V., Mariani L., Gatti G., Paganelli G., Viale G., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
14. Kim T., Agboola O., and Giuliano A. Lymphatic mapping and sentinel lymph node sampling in early-stage breast cancer. A meta-analysis. Cancer 106 1 (2006) 4-16
15. Luini A., Gatti G., Zurrida S., Galimberti V., Paganelli G., and Naninato P. The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life. Breast Cancer Res Treat 89 1 (2005) 69-74
16. Luini A., Gatti G., Ballardini B., Zurrida S., Galimberti V., Veronesi P., et al. Development of axillary surgery in breast cancer. Ann Oncol 16 (2005) 259-262
17. Krontiras H., and Bland K. When is sentinel node biopsy for breast cancer contraindicated?. Surg Oncol 12 (2003) 207-210
18. Cantin J., Scarth H., and Levine M. Clinical practice guidelines for the care and treatment of breast cancer: sentinel lymph node biopsy. JMAC (2001) 166-173
19. Motomura K., Egawa C., Komoike Y., Kataoka T., Naguro S., Kyama H., et al. Sentinel node biopsy for breast cancer: technical aspects and controversies. Breast Cancer 14 (2001) 25-30
20. Chao C., Wong S., Tuttle T.M., Noyes R.E., Carlson D.J., Ley P., et al. Sentinel lymph node biopsy for breast cancer: improvement in results over time. Breast J 10 (2004) 337-344
21. Whitworth P., McMasters K.M., Tafra L., and Edward M.J. State-of the-art lymph node staging for breast cancer in the year 2000. Am J Surg 180 (2000) 262-267
22. Rampaul R.S., Miremadi A., Pinder S.E., Lee A., and Ellis I.O. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 3 (2001) 113-116